XML 22 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The Company recorded the following revenues for the three and six months ended June 30, 2024 and 2023 (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
ORLADEYO:
U.S.$95,909 $72,817 $175,875 $133,666 
Outside of U.S.12,379 8,192 21,280 15,757 
Total ORLADEYO108,288 81,009 197,155 149,423 
Other revenues1,044 1,482 4,938 1,846 
Total revenues$109,332 $82,491 $202,093 $151,269 
ORLADEYO revenues represent total revenues from product sales, collaborative revenues and royalties. Other revenues primarily relate to the Company’s product sales and royalties for peramivir.